OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to extend the human lifespan by 10

ChatGPT maker OpenAI has finalized a version of its new reasoning AI model o3 mini and would be launching it in a couple of weeks, CEO Sam Altman said on Friday.

OpenAI, the leading artificial intelligence (AI) lab, has trained a new AI model known as GPT-4b micro in collaboration with Retro Biosciences. The latter is a longevity science start-up that aims to extend human lifespan by 10 years.

Meta, Apple, Google and other tech companies have been named in a letter penned by Democratic lawmakers, accusing them of cozying up to President-elect Trump.

In its first reaction, the tech giant said, "Suchir was a valued member of our team and we are still heartbroken by his passing."

Microsoft Corp.’s $13 billion investment in OpenAI raises concerns that the tech giant could extend its dominance in cloud computing into the nascent artificial intelligence market, the Federal Trade Commission said in a report released Friday.

Plus: Blue Origin and SpaceX launch big rockets, how magnets could guide lasers to make better computers, how to best work with your IT department and more.

The resulting regulation—or lack thereof—could have repercussions for businesses working on artificial intelligence.

It’s a major get for Murati’s mysterious startup, which has also poached engineers and researchers from a number of other prominent AI firms.

OpenAI is making a foray into scientific discovery with an AI built to help manufacture stem cells. When you think of AI’s contributions to science, you probably think of AlphaFold, the Google DeepMind protein-folding program that earned its creator a Nobel Prize last year.

OpenAI has begun testing a feature that lets new ChatGPT users sign up with only a phone number — no email required. The addition was spotted by software